Pure Global

MEDCONN HbA1c Haemolyser - Indonesia BPOM Medical Device Registration

MEDCONN HbA1c Haemolyser is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207320431. The device is manufactured by SHANGHAI MEDCONN BIOTECHNOLOGY CO.,LTD from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. SEGMED DISTRIBUTION INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
MEDCONN HbA1c Haemolyser
Analysis ID: AKL 20207320431

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. SEGMED DISTRIBUTION INDONESIA

AR Address

SEGMED DISTRIBUSI INDONESIA

Registration Date

Oct 27, 2023

Expiry Date

Feb 21, 2026

Product Type

Haematology Package and Kit

Glycosylated hemoglobin assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing